Company Overview and News

 
Ganesh Chaturthi 2018: 10 popular pandals in Mumbai and how to reach and other details

2018-08-17 freepressjournal.in
Mumbai’s most awaited festival of the year Ganesh Chaturthi is around the corner. The festival has multiple names Ganeshotsav, Vinayaka Chaturthi. Although the festival is celebrated throughout India, the festival is celebrated in much fervour in Maharashtra especially in Mumbai. The festival draws lakhs of devotees from across the country. The chants ‘Ganpati Bappa Morya’ is heard from every corner of the city.
EXCELINDUS 500650

 
Excel Industries Limited - Shareholders meeting

2018-08-10 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXCELINDUS 500650

 
Excel Industries Limited - Updates

2018-08-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXCELINDUS 500650

 
Excel Industries Limited - Updates

2018-07-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXCELINDUS 500650

 
Excel Industries Limited - AGM/Book Closure

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXCELINDUS 500650

 
Excel Industries Limited - Shareholders meeting

2018-07-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXCELINDUS 500650

 
List of stocks on SEBI’s ‘monitor list’ was leaked, suspect traders

2018-06-05 thehindubusinessline
Was a list of stocks that were to be included in Additional Surveillance Measure (ASM), the new category formed by SEBI to check market manipulation, leaked to operators ahead of its official release? A section of stock market brokers and top traders suspect that operators in Mumbai and Gujarat may have had access to the list on May 31 before it was officially put up on stock exchange websites.
517421 ALNSE 500339 513269 MANINDS 533333 RAIN 532497 FCL RADICO BUTTERFLY EXCELINDUS 500650

4
Market Live: Sensex at day#39;s high, Nifty reclaims 10,700; LT up 2% ahead of Q4 nos

2018-05-28 moneycontrol
Buzzing: Capacit’e Infraprojects share price rallied nearly 4 percent after Edelweiss Securities has initiated coverage with Buy rating on the stock and target price of Rs 397.
524715 INDIANB TORNTPHARM MGHOF 532617 HIMATSEIDE 532814 TCHQY 532755 GLKQY PRAJIND 532461 500850 INDHOTEL 500650 GLENMARK 522205 514043 INDIGO JETAIRWAYS 533023 532865 539207 TECHM 539448 M30 PNJZY 532296 TQRRY 500420 SUNPHARMA PNB WABCOINDIA EXCELINDUS MANPASAND MEGH

4
Market Live: Sensex at day#39;s high, Nifty inches towards 10,700; LT up 2% ahead of Q4 nos

2018-05-28 moneycontrol
Market Update: The market is trading at day's high, with the Nifty inching towards 10,700 levels following sharp correction in crude oil prices and appreciation in the rupee.
524715 INDIANB MGHOF 532617 HIMATSEIDE 532814 TCHQY 532755 GLKQY PRAJIND 532461 500650 GLENMARK 522205 514043 INDIGO JETAIRWAYS 533023 532865 539207 TECHM 539448 M30 PNJZY 532296 SUNPHARMA PNB WABCOINDIA EXCELINDUS MANPASAND MEGH

4
Market Live: Sensex strong, Midcap index up over 1%; Nifty IT underperforms

2018-05-28 moneycontrol
Market Update: The market continued to trade strong for the third consecutive day today, with the Sensex rising more than 150 points. Steep fall in crude oil prices and recovery in the rupee from 18-month low boosted investors sentiment.
524715 INDIANB MGHOF 532617 HIMATSEIDE 532814 TCHQY 532755 PRAJIND 532461 500650 522205 514043 INDIGO JETAIRWAYS 532865 539207 TECHM 539448 M30 PNJZY SUNPHARMA PNB EXCELINDUS MANPASAND MEGH

 
Excel Industries Limited - Financial Result Updates

2018-05-28 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXCELINDUS 500650

4
Market Live: Sensex up 200 pts, Midcap extends gains; Manpasand Beverages dips 20%

2018-05-28 moneycontrol
Dr Reddy's Laboratories files lawsuit in US District Court: Shares of Dr Reddy's Laboratories rose 1.3 percent as company filed lawsuit in the United States District Court.
524715 INDIANB MGHOF 532617 HIMATSEIDE 532814 TCHQY 532755 PRAJIND 532461 500650 522205 514043 INDIGO JETAIRWAYS 532865 539207 TECHM 539448 M30 PNJZY SUNPHARMA PNB EXCELINDUS MANPASAND MEGH

4
Market Live: Sensex reclaims 35K, opens up 100 pts; sharp fall in oil prices lift IOC, HPCL, BPCL

2018-05-28 moneycontrol
Rupee Update: The rupee strengthened by 39 paise to 67.39 against the dollar at the interbank forex market today on fresh selling of the greenback by exporters and banks.
522205 524715 INDIANB INDIGO 514043 MGHOF 532617 HIMATSEIDE 532814 JETAIRWAYS TCHQY 532865 532755 539448 TECHM PRAJIND M30 PNJZY 532461 SUNPHARMA PNB EXCELINDUS MEGH 500650

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...